Losartan reduces hematocrit in patients with chronic obstructive pulmonary disease and secondary erythrocytosis

被引：27
作者：
Vlahakos, DV [1 ]
Marathias, K
Kosmas, EN
机构：
[1] Onassis Cardiac Surg Ctr, Athens 17674, Greece
[2] Amalia Fleming Gen Hosp, Athens 15127, Greece
来源：
ANNALS OF INTERNAL MEDICINE | 2001年 / 134卷 / 05期
关键词：
D O I：
10.7326/0003-4819-134-5-200103060-00022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：426 / 427
页数：2
相关论文
共 5 条
[1]   EFFECTS OF ENALAPRIL ON ERYTHROCYTOSIS AFTER RENAL-TRANSPLANTATION [J].
GASTON, RS ;
JULIAN, BA ;
DIETHELM, AG ;
CURTIS, JJ .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (12) :954-955
[2]   Angiotensin II stimulates proliferation of normal early erythroid progenitors [J].
Mrug, M ;
Stopka, T ;
Julian, BA ;
Prchal, JF ;
Prchal, JT .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2310-2314
[3]   Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease [J].
Vlahakos, DV ;
Kosmas, EN ;
Dimopoulou, I ;
Ikonomou, E ;
Jullien, G ;
Vassilakos, P ;
Marathias, KP .
AMERICAN JOURNAL OF MEDICINE, 1999, 106 (02) :158-164
[4]  
VLAHAKOS DV, 1995, CLIN NEPHROL, V43, P53
[5]   ENALAPRIL-ASSOCIATED ANEMIA IN RENAL-TRANSPLANT RECIPIENTS TREATED FOR HYPERTENSION [J].
VLAHAKOS, DV ;
CANZANELLO, VJ ;
MADAIO, MP ;
MADIAS, NE .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (02) :199-205
1